Detalhe da pesquisa
1.
Vaccine effectiveness of recombinant and standard dose influenza vaccines against outpatient illness during 2018-2019 and 2019-2020 calculated using a retrospective test-negative design.
Hum Vaccin Immunother
; 19(1): 2177461, 2023 12 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-36809982
2.
Vaccine effectiveness of recombinant and standard dose influenza vaccines against influenza related hospitalization using a retrospective test-negative design.
Vaccine
; 41(35): 5134-5140, 2023 08 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37474406
3.
Effect of mild COVID-19 on health-related quality of life.
Brain Behav Immun Health
; 28: 100596, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36713477
4.
Blood Inflammatory Biomarkers Differentiate Inpatient and Outpatient Coronavirus Disease 2019 From Influenza.
Open Forum Infect Dis
; 10(3): ofad095, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36949873
5.
Estimating the burden of adult hospitalized RSV infection including special populations.
Vaccine
; 40(31): 4121-4127, 2022 07 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-35667912
6.
Using capture-recapture methods to estimate influenza hospitalization incidence rates.
Influenza Other Respir Viruses
; 16(2): 308-315, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34750974
7.
Using Capture-Recapture Methods to Estimate Influenza Hospitalization Incidence Rates.
medRxiv
; 2021 Sep 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33173888
8.
Corrigendum to "Estimating the burden of adult hospitalized RSV infection including special populations". [Vaccine 40(31) (2022) 4121-4127].
Vaccine
; 40(42): 6187, 2022 Oct 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36100491